Take Action

The 340B Drug Pricing Program was intended to help expand access to discounted medicines for vulnerable patients. Instead, big hospitals, chain pharmacies and pharmacy benefit managers (PBMs) are capturing billions of dollars in profits off the program while patients are left behind with climbing drug costs.

Weak oversight and a lack of accountability in 340B is allowing large corporations, including CVS and Walmart, to boost their margins at the expense of the vulnerable patients the program was intended to help. 

It is encouraging to see action being taken at the federal level with the recent introduction of the 340B ACCESS Act (H.R. 8574), but even more must be done to address the significant abuses of the program.

Congress needs to act now to rid the 340B program of this abuse, ensuring discounts on medicines are going to low-income patients. 

Join us today and send a letter to your member of Congress urging them to demand transparency and accountability in the 340B program — not policies that are giveaways for PBMs, chain pharmacies and hospitals.